Antidepressant effects of ketamine in depressed patients
about
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressantsRestructuring consciousness -the psychedelic state in light of integrated information theoryNeuroplasticity and the next wave of antidepressant strategiesPreclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extractMourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatryKetamine and other glutamate receptor modulators for depression in adultsA Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderRapid antidepressant effects: moving right alongmTOR activation is required for the antidepressant effects of mGluR₂/₃ blockadeReplication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trialGlycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male ratsA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionRapid regulation of depression-related behaviours by control of midbrain dopamine neuronsTowards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersGlutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatmentNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsThe Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and SenescenceKetamine enantiomers in the rapid and sustained antidepressant effectsPractical application of the neuroregenerative properties of ketamine: real world treatment experiencePreclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistComorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic IllnessStress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala.Depression as a Glial-Based Synaptic DysfunctionTreatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as TherapyKetamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on EfficacyPotential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsZinc in the Glutamatergic Theory of DepressionPharmacological approaches to the challenge of treatment-resistant depressionAntidepressant mechanism of ketamine: perspective from preclinical studiesContribution of NMDA receptors to dorsolateral prefrontal cortical networks in primatesAntidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a reviewNeurological diseases and painThe neurology of mTORKetamine, sleep, and depression: current status and new questionsGlial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Novel NMDA receptor modulators: an updateReview of pharmacological treatment in mood disorders and future directions for drug development.The neurobiology of anhedonia and other reward-related deficitsAntidepressant actions of ketamine: from molecular mechanisms to clinical practice
P2860
Q21129276-1EB9A6D1-EDB9-4B20-98DD-82A0FB745014Q21129375-E41DB60A-6058-451B-B178-627F3848E07EQ21129480-8B1D99A4-D2A2-4DEC-903C-FD388BFD4817Q21132322-A9B9DB3B-E51E-4E0D-96F6-A4CCB4942EACQ21203922-B9A734A9-4877-43C7-B337-68601278D307Q24186746-9E3681D9-616F-4E73-94E9-F8800016E9F5Q24602988-FD72D666-BAB5-409D-BD41-F8C51B863A5CQ24614410-961B2250-6136-4975-8247-D8DF523232DBQ24617166-F5BB3F77-3979-4398-AE66-2FD713837126Q24629398-BCC9398D-064E-4977-AF31-4DB8DABF6305Q24629780-DD0530C9-23F1-48BA-8BDC-EB6C831363BEQ24630153-F5659F58-50D1-4D6E-A227-90D59BC358F7Q24630584-C406B69F-3317-4421-82F7-3806913273F2Q24632936-F7529FC3-FB07-43BF-985D-78E4077ADB5BQ24633004-E802C6F4-4C04-4073-87D2-33F44092C600Q24656267-9A0D12E8-0209-40CA-9CBC-FD1752004DD9Q26745558-320AEA4F-78AC-464A-844F-F8002B8B64A3Q26746141-F3CF7067-3810-4110-91DD-CE9DB472E046Q26748766-9ACE8B23-5912-4DB0-A93E-1394AE7994A0Q26750021-69478C7C-D416-44A9-8C49-F2512E831338Q26765501-FB5B991A-0234-43F6-8A2C-D39B21C9EE9BQ26769043-8803C1BF-74F2-4D31-86CE-A7551C527B3AQ26772830-3F2C094D-B6B5-4F96-AFBB-3A00174A0154Q26773084-CE6D9B07-52CE-4D02-9D04-F218AE460C93Q26778251-88A06653-56DB-4771-9BF1-AA2CF7476B63Q26782274-CF6CAA34-3E8D-40DE-8322-ACAEA9C1CB26Q26786214-9485A750-4F7C-4C82-9B4A-B55821CCFAA4Q26798241-13F5E323-BB5F-4FDC-ADF1-9D7D25B0E7CBQ26800231-CE1A9063-D314-42C7-9BC9-B521F34882B4Q26820417-65FFBC97-849B-485B-B00E-D171D91236F6Q26822244-62F8799F-B81B-485A-BB45-F3EF5802AF77Q26822891-ED70062D-C097-41BC-9684-2EF2F9090063Q26824286-A1DEF744-51DB-4949-9B55-1BC91ED83383Q26828564-17907545-7722-48D9-9448-AB1A48B1BCC4Q26829556-9D41A784-4524-42DC-B423-622156C8EE0CQ26830533-5B31105D-7B29-465C-ABA9-02209AF13D8AQ26849614-6D8226C8-B387-49F2-9073-5EB517940C25Q26853509-8496ED00-A5A4-4BC0-990E-5AC48E0DD4AFQ26853518-7EE6CCA6-08D6-41DC-91AA-27F223408DF1Q26995879-69D117B3-CE6D-40B4-B608-1656FA8717D9
P2860
Antidepressant effects of ketamine in depressed patients
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antidepressant effects of ketamine in depressed patients
@ast
Antidepressant effects of ketamine in depressed patients
@en
type
label
Antidepressant effects of ketamine in depressed patients
@ast
Antidepressant effects of ketamine in depressed patients
@en
prefLabel
Antidepressant effects of ketamine in depressed patients
@ast
Antidepressant effects of ketamine in depressed patients
@en
P2093
P3181
P1476
Antidepressant effects of ketamine in depressed patients
@en
P2093
Cappiello A
Charney DS
Heninger GR
Krystal JH
P3181
P356
10.1016/S0006-3223(99)00230-9
P407
P577
2000-02-15T00:00:00Z